Arkolith/Insider Trading/THRX/Form 4

Gordon Carl L

Director, 10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Nov 9, 2022
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2022Buy(P)192K$5.21$1.0M16.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-22-001158) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML